Greenwich LifeSciences (GLSI) Common Equity (2019 - 2026)
Greenwich LifeSciences (GLSI) reported Common Equity of $5.27 million for Q1 2026, compared with $200,483 a year earlier.
Powered by 
Analysis
Greenwich LifeSciences (GLSI) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Greenwich LifeSciences posted Common Equity of $353,217, down 61.1% from FY2024.
- Common Equity has declined for five consecutive years, with a five-year compound annual growth rate of -58.2% (FY2020 to FY2025).
- By year, Common Equity came in at $908,626 in FY2024 (-86.4%), $6.7 million in FY2023 (-49.3%), $13.21 million in FY2022 (-50.8%) and $26.83 million in FY2021 (-2.9%).
- The Q1 2026 figure ranks as the highest quarterly Common Equity since Q2 2024.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 511.1%); the low point was Q1 2025 (a decline of 96.1%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $353,217 (Q4 2025), $2.18 million (Q3 2025) and $1.44 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Greenwich LifeSciences | 272.64 Mn | 272.64 Mn | - | 5.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.27 Mn |
| Dec 31, 2025 | 353,217.00 |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 200,483.00 |
| Dec 31, 2024 | 908,626.00 |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 5.88 Mn |
| Mar 31, 2024 | 5.12 Mn |
| Dec 31, 2023 | 6.70 Mn |
| Sep 30, 2023 | 8.85 Mn |
| Jun 30, 2023 | 10.65 Mn |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 13.21 Mn |
| Sep 30, 2022 | 15.41 Mn |
| Jun 30, 2022 | 16.97 Mn |
| Mar 31, 2022 | 19.51 Mn |
| Dec 31, 2021 | 26.83 Mn |
| Sep 30, 2021 | 28.46 Mn |
| Jun 30, 2021 | 29.16 Mn |
API Access
Greenwich LifeSciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GLSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GLSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GLSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();